Why Kiyatec exists
Kiyatec provides CLIA-certified functional testing for high-grade glioma brain cancer. Drugs are applied to fresh tumor tissue and the response is observed, with results in two days to six weeks. For glioma patients deciding on treatment, ex vivo response data can add confidence that a drug or combination is likely to work before it is administered.
- 1
Tumor sample collection
The patient's doctor removes a part of the tumor and sends it to the Kiyatec lab.
- 2
Tissue arrives within 24 hours
The lab receives the tissue within 24 hours.
- 3
3D testing against cancer drugs
The lab creates spheroids from the tumor tissue and treats them with cancer drugs to measure response.
- 4
Results to the doctor
Results clearly show which chemotherapies killed the cancer cells and which ones did not, and are sent to the doctor.
Prefer the source? Kiyatec (CLIA-certified, high-grade glioma brain cancer)'s own site has more.
